Trends in diabetes and obesity in Samoa over 35 years, 1978–2013

S. Lin, T. Naseri, C. Linhart, S. Morrell, R. Taylor, S. T. Mcgarvey, D. J. Magliano, P. Zimmet

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Aims: Population surveys of Type 2 diabetes mellitus and obesity conducted in Samoa over three decades have used varying methodologies and definitions. This study standardizes measures, and trends of Type 2 diabetes mellitus and obesity for 1978–2013 are projected to 2020 for adults aged 25–64 years. Methods: Unit records from eight surveys (n = 12 516) were adjusted to the previous census for Division of residence, sex and age to improve national representativeness. Type 2 diabetes mellitus is defined as a fasting plasma glucose ≥ 7.0 mmol/l and/or on medication. Obesity is defined as BMI ≥ 30 kg/m2. Random effects meta-regression was employed to assess time trends following logit transformation. Poisson regression from strata was used to assess the effects of mean BMI changes on Type 2 diabetes mellitus period trends. Results: Over 1978–2013, Type 2 diabetes mellitus prevalence increased from 1.2% to 19.6% in men (2.3% per 5 years), and from 2.2% to 19.5% in women (2.2% per 5 years). Obesity prevalence increased from 27.7% to 53.1% in men (3.6% per 5 years) and from 44.4% to 76.7% (4.5% per 5 years) in women. Type 2 diabetes mellitus and obesity prevalences increased in all age groups. From period trends, Type 2 diabetes mellitus prevalence in 2020 is projected to be 26% in men and women. Projected obesity prevalence is projected to be 59% in men and 81% in women. Type 2 diabetes mellitus period trends attributable to BMI increase are estimated as 31% (men) and 16% (women), after adjusting for age. Conclusion: This is the first study to produce trends of Type 2 diabetes mellitus and obesity in Samoa based on standardized data from population surveys. Type 2 diabetes mellitus is equally prevalent in both sexes, and obesity is widespread. Type 2 diabetes mellitus prevalence in Samoa is likely to continue to increase in the near future.

LanguageEnglish
Pages654-661
Number of pages8
JournalDiabetic Medicine
Volume34
Issue number5
DOIs
Publication statusPublished - 1 May 2017

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Lin, S., Naseri, T., Linhart, C., Morrell, S., Taylor, R., Mcgarvey, S. T., ... Zimmet, P. (2017). Trends in diabetes and obesity in Samoa over 35 years, 1978–2013. Diabetic Medicine, 34(5), 654-661. https://doi.org/10.1111/dme.13197
Lin, S. ; Naseri, T. ; Linhart, C. ; Morrell, S. ; Taylor, R. ; Mcgarvey, S. T. ; Magliano, D. J. ; Zimmet, P. / Trends in diabetes and obesity in Samoa over 35 years, 1978–2013. In: Diabetic Medicine. 2017 ; Vol. 34, No. 5. pp. 654-661.
@article{7de08b9d51264131b9ac762ac133267a,
title = "Trends in diabetes and obesity in Samoa over 35 years, 1978–2013",
abstract = "Aims: Population surveys of Type 2 diabetes mellitus and obesity conducted in Samoa over three decades have used varying methodologies and definitions. This study standardizes measures, and trends of Type 2 diabetes mellitus and obesity for 1978–2013 are projected to 2020 for adults aged 25–64 years. Methods: Unit records from eight surveys (n = 12 516) were adjusted to the previous census for Division of residence, sex and age to improve national representativeness. Type 2 diabetes mellitus is defined as a fasting plasma glucose ≥ 7.0 mmol/l and/or on medication. Obesity is defined as BMI ≥ 30 kg/m2. Random effects meta-regression was employed to assess time trends following logit transformation. Poisson regression from strata was used to assess the effects of mean BMI changes on Type 2 diabetes mellitus period trends. Results: Over 1978–2013, Type 2 diabetes mellitus prevalence increased from 1.2{\%} to 19.6{\%} in men (2.3{\%} per 5 years), and from 2.2{\%} to 19.5{\%} in women (2.2{\%} per 5 years). Obesity prevalence increased from 27.7{\%} to 53.1{\%} in men (3.6{\%} per 5 years) and from 44.4{\%} to 76.7{\%} (4.5{\%} per 5 years) in women. Type 2 diabetes mellitus and obesity prevalences increased in all age groups. From period trends, Type 2 diabetes mellitus prevalence in 2020 is projected to be 26{\%} in men and women. Projected obesity prevalence is projected to be 59{\%} in men and 81{\%} in women. Type 2 diabetes mellitus period trends attributable to BMI increase are estimated as 31{\%} (men) and 16{\%} (women), after adjusting for age. Conclusion: This is the first study to produce trends of Type 2 diabetes mellitus and obesity in Samoa based on standardized data from population surveys. Type 2 diabetes mellitus is equally prevalent in both sexes, and obesity is widespread. Type 2 diabetes mellitus prevalence in Samoa is likely to continue to increase in the near future.",
author = "S. Lin and T. Naseri and C. Linhart and S. Morrell and R. Taylor and Mcgarvey, {S. T.} and Magliano, {D. J.} and P. Zimmet",
year = "2017",
month = "5",
day = "1",
doi = "10.1111/dme.13197",
language = "English",
volume = "34",
pages = "654--661",
journal = "Diabetic Medicine",
issn = "0742-3071",
publisher = "Wiley-Blackwell",
number = "5",

}

Lin, S, Naseri, T, Linhart, C, Morrell, S, Taylor, R, Mcgarvey, ST, Magliano, DJ & Zimmet, P 2017, 'Trends in diabetes and obesity in Samoa over 35 years, 1978–2013', Diabetic Medicine, vol. 34, no. 5, pp. 654-661. https://doi.org/10.1111/dme.13197

Trends in diabetes and obesity in Samoa over 35 years, 1978–2013. / Lin, S.; Naseri, T.; Linhart, C.; Morrell, S.; Taylor, R.; Mcgarvey, S. T.; Magliano, D. J.; Zimmet, P.

In: Diabetic Medicine, Vol. 34, No. 5, 01.05.2017, p. 654-661.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Trends in diabetes and obesity in Samoa over 35 years, 1978–2013

AU - Lin, S.

AU - Naseri, T.

AU - Linhart, C.

AU - Morrell, S.

AU - Taylor, R.

AU - Mcgarvey, S. T.

AU - Magliano, D. J.

AU - Zimmet, P.

PY - 2017/5/1

Y1 - 2017/5/1

N2 - Aims: Population surveys of Type 2 diabetes mellitus and obesity conducted in Samoa over three decades have used varying methodologies and definitions. This study standardizes measures, and trends of Type 2 diabetes mellitus and obesity for 1978–2013 are projected to 2020 for adults aged 25–64 years. Methods: Unit records from eight surveys (n = 12 516) were adjusted to the previous census for Division of residence, sex and age to improve national representativeness. Type 2 diabetes mellitus is defined as a fasting plasma glucose ≥ 7.0 mmol/l and/or on medication. Obesity is defined as BMI ≥ 30 kg/m2. Random effects meta-regression was employed to assess time trends following logit transformation. Poisson regression from strata was used to assess the effects of mean BMI changes on Type 2 diabetes mellitus period trends. Results: Over 1978–2013, Type 2 diabetes mellitus prevalence increased from 1.2% to 19.6% in men (2.3% per 5 years), and from 2.2% to 19.5% in women (2.2% per 5 years). Obesity prevalence increased from 27.7% to 53.1% in men (3.6% per 5 years) and from 44.4% to 76.7% (4.5% per 5 years) in women. Type 2 diabetes mellitus and obesity prevalences increased in all age groups. From period trends, Type 2 diabetes mellitus prevalence in 2020 is projected to be 26% in men and women. Projected obesity prevalence is projected to be 59% in men and 81% in women. Type 2 diabetes mellitus period trends attributable to BMI increase are estimated as 31% (men) and 16% (women), after adjusting for age. Conclusion: This is the first study to produce trends of Type 2 diabetes mellitus and obesity in Samoa based on standardized data from population surveys. Type 2 diabetes mellitus is equally prevalent in both sexes, and obesity is widespread. Type 2 diabetes mellitus prevalence in Samoa is likely to continue to increase in the near future.

AB - Aims: Population surveys of Type 2 diabetes mellitus and obesity conducted in Samoa over three decades have used varying methodologies and definitions. This study standardizes measures, and trends of Type 2 diabetes mellitus and obesity for 1978–2013 are projected to 2020 for adults aged 25–64 years. Methods: Unit records from eight surveys (n = 12 516) were adjusted to the previous census for Division of residence, sex and age to improve national representativeness. Type 2 diabetes mellitus is defined as a fasting plasma glucose ≥ 7.0 mmol/l and/or on medication. Obesity is defined as BMI ≥ 30 kg/m2. Random effects meta-regression was employed to assess time trends following logit transformation. Poisson regression from strata was used to assess the effects of mean BMI changes on Type 2 diabetes mellitus period trends. Results: Over 1978–2013, Type 2 diabetes mellitus prevalence increased from 1.2% to 19.6% in men (2.3% per 5 years), and from 2.2% to 19.5% in women (2.2% per 5 years). Obesity prevalence increased from 27.7% to 53.1% in men (3.6% per 5 years) and from 44.4% to 76.7% (4.5% per 5 years) in women. Type 2 diabetes mellitus and obesity prevalences increased in all age groups. From period trends, Type 2 diabetes mellitus prevalence in 2020 is projected to be 26% in men and women. Projected obesity prevalence is projected to be 59% in men and 81% in women. Type 2 diabetes mellitus period trends attributable to BMI increase are estimated as 31% (men) and 16% (women), after adjusting for age. Conclusion: This is the first study to produce trends of Type 2 diabetes mellitus and obesity in Samoa based on standardized data from population surveys. Type 2 diabetes mellitus is equally prevalent in both sexes, and obesity is widespread. Type 2 diabetes mellitus prevalence in Samoa is likely to continue to increase in the near future.

UR - http://www.scopus.com/inward/record.url?scp=84990909073&partnerID=8YFLogxK

U2 - 10.1111/dme.13197

DO - 10.1111/dme.13197

M3 - Article

VL - 34

SP - 654

EP - 661

JO - Diabetic Medicine

T2 - Diabetic Medicine

JF - Diabetic Medicine

SN - 0742-3071

IS - 5

ER -

Lin S, Naseri T, Linhart C, Morrell S, Taylor R, Mcgarvey ST et al. Trends in diabetes and obesity in Samoa over 35 years, 1978–2013. Diabetic Medicine. 2017 May 1;34(5):654-661. https://doi.org/10.1111/dme.13197